📅 Published
March 21, 2026
(Saturday)

Watch: Two Mega Tailwinds for Indian Biotech

GLP-1 Drug patent expiry + Rupee at ₹94 = Golden moment for biotech exporters.

Disclaimer: Educational only. Manish Goel, SEBI Reg. Advisor (INA100007736)

📢 Join Our Telegram Channel

Get daily value investing lessons, stock analysis & Titan Biotech updates — delivered straight to your phone!

✈️ Join @longtermequityy on Telegram

🔔 Free • No spam • Value investing insights daily

Video: Two Mega Tailwinds for Indian Biotech — GLP-1 Drug + Rupee ₹94
author avatar
Manish Goel
Manish Goel is a long-term value investor and the founder of Manish Goel Stocks, where he publishes daily, plain-English lessons on fundamental analysis for Indian investors. His writing focuses on reading annual reports, decoding financial ratios, spotting red flags, and building the patience and discipline that compounding rewards. Every article here is educational — never a buy or sell call — and free to read.
See Full Bio